Search clinical trials for: Digoxin Fimasartan

Total 278 results

Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers

Essential Hypertension
First Affiliated Hospital Xi'an Jiaotong University

Completed

The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects

Healthy

China
Boryung Pharmaceutical Co., Ltd

Completed

Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects

Healthy

Korea, Republic of
Boryung Pharmaceutical Co., Ltd
Seoul National University Hospital

Completed

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers

Renal Impairment

Korea, Republic of
Boryung Pharmaceutical Co., Ltd
Seoul National University Hospital; Kyungpook National University Hospital

Completed

Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers (Fimasartan)

Essential Hypertension
Boryung Pharmaceutical Co., Ltd
Yonsei University; Kyungpook National University Hospital

Completed

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

Essential Hypertension | Hepatic Impairment

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Healthy
Boryung Pharmaceutical Co., Ltd

Completed

Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K) (Fimasartan)

Essential Hypertension
Boryung Pharmaceutical Co., Ltd
Chonbuk National University Hospital; Samsung Medical Center; Asan Medical Center and other collaborators

Completed

A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy

Essential Hypertension

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion (STIFFNESS)

Hypertension

Korea, Republic of
Boryung Pharmaceutical Co., Ltd
Covance

Completed

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

Essential Hypertension
Seoul National University Hospital
Samsung Medical Center; Chonnam National University Hospital; Korea University... and other collaborators

Unknown

A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial) (ALFA)

Critical Stenosis of Aortic Valve

Korea, Republic of
Assistance Publique - Hôpitaux de Paris
Cancer Research and Personalized Medicine (Carpem); Laboratoire d'excellence...

Unknown

Potentiation of Cisplatin-based Chemotherapy by Digoxin in Advanced Unresectable Head and Neck Cancer Patients (DIGHANC)

Head and Neck Cancer

France
Seoul National University Bundang Hospital

Completed

Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG

Hypertension | Left Ventricular Hypertrophy
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects

Healthy

China
Boryung Pharmaceutical Co., Ltd
Samsung Medical Center; Asan Medical Center; Seoul National University Hospital; Seoul National University Bundang Hospital and other collaborators

Completed

Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients

Hypertension

Korea, Republic of
AstraZeneca

Completed

Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea; Boryung Pharmaceutical Co., Ltd

Terminated

Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)

Coronary Artery Disease

Korea, Republic of
Boryung Pharmaceutical Co., Ltd
Covance

Completed

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

Essential Hypertension
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

Essential Hypertension
University of California, Los Angeles

Completed

Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion

Abortion, Induced
Asan Medical Center
Boryung Pharmaceutical Co., Ltd

Completed

A Trial of Fimasartan for Early Diastolic Heart Failure (FINE)

Hypertension

Korea, Republic of
Hospital Ana Nery

Unknown

Intensive Versus Conventional Digoxin Use in Patients With Heart Failure (ICHF)

Heart Failure

Brazil
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

Hypertension | Hyperlipidemia

Korea, Republic of
Cairo University

Completed

A Prospective Study of Different Digoxin Treatment Regimens in Egyptian Hospital

Atrial Fibrillation
Seoul National University Bundang Hospital

Recruiting

Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension (FAoRAS)

Hypertension | Diabetes Mellitus, Type 2 | Atherosclerosis | Renin Hypertension

Korea, Republic of
Genzyme, a Sanofi Company

Completed

A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy Adults

Healthy Volunteer

United States
White, Katharine O'Connell, M.D., M.P.H.
Society of Family Planning

Completed

A Trial of Digoxin Before Second-Trimester Abortion

Induced Abortion

United States
Boryung Pharmaceutical Co., Ltd
Pusan National University Hospital; Ulsan University Hospital; Daegu Catholic... and other collaborators

Completed

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Hypertension

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia (FIMASTAR)

Hypertension and Dyslipidemia

Korea, Republic of
GlaxoSmithKline

Completed

An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed

Epilepsy

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects

Hypertension
Stendhal Americas, S.A.

Completed

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension (FIRME-1)

Hypertension, Essential

Mexico
Assistance Publique - Hôpitaux de Paris

Unknown

Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma (KADIG 01)

Kaposi' s Sarcoma | Classic Kaposi' s Sarcoma | Endemic Kaposi' s Sarcoma | Lymph Angio Proliferations

France
Boryung Pharmaceutical Co., Ltd
Kyungpook National University Hospital

Completed

to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin

Hypertension

Korea, Republic of
Pfizer
Medivation, Inc.

Completed

Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects

Alzheimer Disease | Huntington Disease

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia (FIESTA)

Essential Hypertension, Dyslipidemia

Korea, Republic of
University of Monastir

Completed

Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients

Atrial Fibrillation

Tunisia
Hoffmann-La Roche

Completed

A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers

Healthy Volunteer

United Kingdom
Cocco, Giuseppe, M.D.
Cardiology Office, Rheinfelden, Switzerland

Completed

Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function (DIGvsIVA)

Heart Failure | Atrial Fibrillation

Switzerland
AnHeart Therapeutics Inc.

Completed

A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin

Solid Tumor

China
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers.

Healthy
University of Leeds

Not yet recruiting

Digoxin and Senolysis in Heart Failure and Diabetes Mellitus

Diabetes Mellitus, Type 2 | Heart Failure, Systolic

United Kingdom
The Alfred

Completed

Digoxin Withdrawal in Stable Heart Failure

Heart Failure

Australia
Boryung Pharmaceutical Co., Ltd

Completed

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia

Essential Hypertension, Dyslipidemia

Korea, Republic of
University Hospital, Basel, Switzerland
ETH Zurich - The Aceto Lab

Completed

Digoxin Induced Dissolution of CTC Clusters

Breast Cancer | Circulating Tumor Cells (CTCs)

Switzerland
Boryung Pharmaceutical Co., Ltd
Pusan National University Hospital; Asan Medical Center; Chonnam National University... and other collaborators

Completed

Fimasartan/Amlodipine Combination Phase III

Essential Hypertension

Korea, Republic of
Boryung Pharmaceutical Co., Ltd
Kyunghee university hospital A Drug Analytical Laboratory

Completed

To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets

Hypertension

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia (FIRST)

Dyslipidemia | Essential Hypertension

Korea, Republic of
National Institute on Aging (NIA)
University of Toledo Health Science Campus

Unknown

Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease

Hypertension | Hemodialysis

United States

3

Subscribe